Objective
To evaluate the efficacy of the 7000 series and the Plasma BAR in reducing airborne bacteria: Escherichia coli and Staphylococcus aureus (MRSA), mold: Aspergillus niger and Cladosporium cladosporioides, and yeast Candida albicans.
Methodology
An environmental chamber was set up for the testing. A nebulizer was connected to an air compressor with 1/4-inch plastic tubing and to the environmental test chamber through one of the openings.
Summary of Results
Testing showed a 99.43% reduction of Escherichia coli, an 81.67% reduction of Staphylococcus aureus, a 97.14% reduction of Aspergillus niger, a 97.69% reduction of Candida albicans and 36.27% reduction of Cladosporium cladospoioides.
USA Headquarters
Stamford, Connecticut
Call: 1 866 508 1118 Email: info@wellairsolutions.com
Ireland Headquarters
DCU Innovation Campus Old Finglas Road Glasnevin, Dublin 11
Call: +353 1 907 2750 Email: info@wellairsolutions.com